Randomized Controlled Trial Evaluating the Use of Zoledronic Acid in Duchenne Muscular Dystrophy.

Margaret Zacharin Angelina S LimJames GryllakisAris SiafarikasCraig JefferiesJulie BriodyNatasha L HeatherJanne PitkinJaiman EmmanuelKatherine J LeeXiaofang WangPeter J SimmCraig F Munns

Published in: The Journal of clinical endocrinology and metabolism (2021)

ZA improved BMD in glucocorticoid-dependent DMD boys. Although the small cohort precluded demonstrable fracture benefit, improved BMD might reduce incident vertebral fracture.

Keyphrases

duchenne muscular dystrophy
randomized controlled trial
muscular dystrophy
study protocol
hip fracture
cardiovascular disease
bone mineral density
systematic review
clinical trial
body composition
postmenopausal women
double blind